Skip to main content

Advertisement

SpringerLink
Log in

Recent advances in assays for the fragile X-related disorders

  • Review
  • Published:
Human Genetics Aims and scope Submit manuscript

Abstract

The fragile X-related disorders are a group of three clinical conditions resulting from the instability of a CGG-repeat tract at the 5′ end of the FMR1 transcript. Fragile X-associated tremor/ataxia syndrome (FXTAS) and fragile X-associated primary ovarian insufficiency (FXPOI) are disorders seen in carriers of FMR1 alleles with 55–200 repeats. Female carriers of these premutation (PM) alleles are also at risk of having a child who has an FMR1 allele with >200 repeats. Most of these full mutation (FM) alleles are epigenetically silenced resulting in a deficit of the FMR1 gene product, FMRP. This results in fragile X Syndrome (FXS), the most common heritable cause of intellectual disability and autism. The diagnosis and study of these disorders is challenging, in part because the detection of alleles with large repeat numbers has, until recently, been either time-consuming or unreliable. This problem is compounded by the mosaicism for repeat length and/or DNA methylation that is frequently seen in PM and FM carriers. Furthermore, since AGG interruptions in the repeat tract affect the risk that a FM allele will be maternally transmitted, the ability to accurately detect these interruptions in female PM carriers is an additional challenge that must be met. This review will discuss some of the pros and cons of some recently described assays for these disorders, including those that detect FMRP levels directly, as well as emerging technologies that promise to improve the diagnosis of these conditions and to be useful in both basic and translational research settings.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  • Adayev T, LaFauci G, Dobkin C, Caggana M, Wiley V, Field M, Wotton T, Kascsak R, Nolin SL, Glicksman A, Hosmer N, Brown WT (2014) Fragile X protein in newborn dried blood spots. BMC Med Genet 15:119. doi:10.1186/s12881-014-0119-0

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Ardui S, Race V, Zablotskaya A, Hestand MS, Van Esch H, Devriendt K, Matthijs G, Vermeesch JR (2017) Detecting AGG interruptions in male and female FMR1 premutation carriers by single-molecule sequencing. Hum Mutat 38:324–331. doi:10.1002/humu.23150

    Article  CAS  PubMed  Google Scholar 

  • Basuta K, Narcisa V, Chavez A, Kumar M, Gane L, Hagerman R, Tassone F (2011) Clinical phenotypes of a juvenile sibling pair carrying the fragile X premutation. Am J Med Genet A 155A:519–525. doi:10.1002/ajmg.a.33446

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Basuta K, Schneider A, Gane L, Polussa J, Woodruff B, Pretto D, Hagerman R, Tassone F (2015) High functioning male with fragile X syndrome and fragile X-associated tremor/ataxia syndrome. Am J Med Genet A 167A:2154–2161. doi:10.1002/ajmg.a.37125

    Article  PubMed  Google Scholar 

  • Brown WT, Nolin S, Houck G Jr, Ding X, Glicksman A, Li SY, Stark-Houck S, Brophy P, Duncan C, Dobkin C, Jenkins E (1996) Prenatal diagnosis and carrier screening for fragile X by PCR. Am J Med Genet 64:191–195. doi:10.1002/(SICI)1096-8628(19960712)64:1<191:AID-AJMG34>3.0.CO;2-G

    Article  CAS  PubMed  Google Scholar 

  • Brykczynska U, Pecho-Vrieseling E, Thiemeyer A, Klein J, Fruh I, Doll T, Manneville C, Fuchs S, Iazeolla M, Beibel M, Roma G, Naumann U, Kelley N, Oakeley EJ, Mueller M, Gomez-Mancilla B, Buhler M, Tabolacci E, Chiurazzi P, Neri G, Bouwmeester T, Di Giorgio FP, Fodor BD (2016) CGG repeat-induced FMR1 silencing depends on the expansion size in human iPSCs and neurons carrying unmethylated full mutations. Stem Cell Rep 7:1059–1071. doi:10.1016/j.stemcr.2016.10.004

    Article  CAS  Google Scholar 

  • Cecconi M, Forzano F, Rinaldi R, Cappellacci S, Grammatico P, Faravelli F, Dagna Bricarelli F, Di Maria E, Grasso M (2008) A single nucleotide variant in the FMR1 CGG repeat results in a “Pseudodeletion” and is not associated with the fragile X syndrome phenotype. J Mol Diagn 10:272–275. doi:10.2353/jmoldx.2008.070163

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Chen L, Hadd A, Sah S, Filipovic-Sadic S, Krosting J, Sekinger E, Pan R, Hagerman PJ, Stenzel TT, Tassone F, Latham GJ (2010) An information-rich CGG repeat primed PCR that detects the full range of fragile X expanded alleles and minimizes the need for southern blot analysis. J Mol Diagn 12:589–600. doi:10.2353/jmoldx.2010.090227

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Chen L, Hadd A, Sah S, Houghton JF, Filipovic-Sadic S, Zhang W, Hagerman PJ, Tassone F, Latham GJ (2011) High-resolution methylation polymerase chain reaction for fragile X analysis: evidence for novel FMR1 methylation patterns undetected in Southern blot analyses. Genet Med 13:528–538. doi:10.1097/GIM.0b013e31820a780f

    Article  PubMed  PubMed Central  Google Scholar 

  • Chong SS, Eichler EE, Nelson DL, Hughes MR (1994) Robust amplification and ethidium-visible detection of the fragile X syndrome CGG repeat using Pfu polymerase. Am J Med Genet 51:522–526. doi:10.1002/ajmg.1320510447

    Article  CAS  PubMed  Google Scholar 

  • Coffee B, Zhang F, Warren ST, Reines D (1999) Acetylated histones are associated with FMR1 in normal but not fragile X-syndrome cells. Nat Genet 22:98–101. doi:10.1038/8807

    Article  CAS  PubMed  Google Scholar 

  • Coffee B, Zhang F, Ceman S, Warren ST, Reines D (2002) Histone modifications depict an aberrantly heterochromatinized FMR1 gene in fragile X syndrome. Am J Hum Genet 71:923–932. doi:10.1086/342931

    Article  PubMed  PubMed Central  Google Scholar 

  • Coffee B, Ikeda M, Budimirovic DB, Hjelm LN, Kaufmann WE, Warren ST (2008) Mosaic FMR1 deletion causes fragile X syndrome and can lead to molecular misdiagnosis: a case report and review of the literature. Am J Med Genet A 146A:1358–1367. doi:10.1002/ajmg.a.32261

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Coffee B, Keith K, Albizua I, Malone T, Mowrey J, Sherman SL, Warren ST (2009) Incidence of fragile X syndrome by newborn screening for methylated FMR1 DNA. Am J Hum Genet 85:503–514. doi:10.1016/j.ajhg.2009.09.007

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Collins SC, Bray SM, Suhl JA, Cutler DJ, Coffee B, Zwick ME, Warren ST (2010a) Identification of novel FMR1 variants by massively parallel sequencing in developmentally delayed males. Am J Med Genet A 152A:2512–2520. doi:10.1002/ajmg.a.33626

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Collins SC, Coffee B, Benke PJ, Berry-Kravis E, Gilbert F, Oostra B, Halley D, Zwick ME, Cutler DJ, Warren ST (2010b) Array-based FMR1 sequencing and deletion analysis in patients with a fragile X syndrome-like phenotype. PLoS One 5:e9476. doi:10.1371/journal.pone.0009476

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Dahl C, Gronskov K, Larsen LA, Guldberg P, Brondum-Nielsen K (2007) A homogeneous assay for analysis of FMR1 promoter methylation in patients with fragile X syndrome. Clin Chem 53:790–793. doi:10.1373/clinchem.2006.080762

    Article  CAS  PubMed  Google Scholar 

  • de Graaff E, Rouillard P, Willems PJ, Smits AP, Rousseau F, Oostra BA (1995) Hotspot for deletions in the CGG repeat region of FMR1 in fragile X patients. Hum Mol Genet 4:45–49

    Article  PubMed  Google Scholar 

  • de Graaff E, de Vries BB, Willemsen R, van Hemel JO, Mohkamsing S, Oostra BA, van den Ouweland AM (1996) The fragile X phenotype in a mosaic male with a deletion showing expression of the FMR1 protein in 28% of the cells. Am J Med Genet 64:302–308. doi:10.1002/(SICI)1096-8628(19960809)64:2<302:AID-AJMG14>3.0.CO;2-J

    Article  PubMed  Google Scholar 

  • Dejeux E, El abdalaoui H, Gut IG, Tost J (2009) Identification and quantification of differentially methylated loci by the pyrosequencing technology. Methods Mol Biol 507:189–205. doi:10.1007/978-1-59745-522-0_15

    Article  CAS  PubMed  Google Scholar 

  • Devys D, Lutz Y, Rouyer N, Bellocq JP, Mandel JL (1993) The FMR-1 protein is cytoplasmic, most abundant in neurons and appears normal in carriers of a fragile X premutation. Nat Genet 4:335–340. doi:10.1038/ng0893-335

    Article  CAS  PubMed  Google Scholar 

  • Eichler EE, Holden JJ, Popovich BW, Reiss AL, Snow K, Thibodeau SN, Richards CS, Ward PA, Nelson DL (1994) Length of uninterrupted CGG repeats determines instability in the FMR1 gene. Nat Genet 8:88–94. doi:10.1038/ng0994-88

    Article  CAS  PubMed  Google Scholar 

  • Elias MH, Ankathil R, Salmi AR, Sudhikaran W, Limprasert P, Zilfalil BA (2011) A new method for FMR1 gene methylation screening by multiplex methylation-specific real-time polymerase chain reaction. Genet Test Mol Biomark 15:387–393. doi:10.1089/gtmb.2010.0191

    Article  CAS  Google Scholar 

  • Feng Y, Zhang F, Lokey LK, Chastain JL, Lakkis L, Eberhart D, Warren ST (1995) Translational suppression by trinucleotide repeat expansion at FMR1. Science 268:731–734

    Article  CAS  PubMed  Google Scholar 

  • Filipovic-Sadic S, Sah S, Chen L, Krosting J, Sekinger E, Zhang W, Hagerman PJ, Stenzel TT, Hadd AG, Latham GJ, Tassone F (2010) A novel FMR1 PCR method for the routine detection of low abundance expanded alleles and full mutations in fragile X syndrome. Clin Chem 56:399–408. doi:10.1373/clinchem.2009.136101

    CAS  PubMed  PubMed Central  Google Scholar 

  • Fry M, Loeb LA (1994) The fragile X syndrome d(CGG)n nucleotide repeats form a stable tetrahelical structure. Proc Natl Acad Sci USA 91:4950–4954

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Garcia Arocena D, de Diego Y, Oostra BA, Willemsen R, Mirta Rodriguez M (2000) A fragile X case with an amplification/deletion mosaic pattern. Hum Genet 106:366–369

    Article  CAS  PubMed  Google Scholar 

  • Gatta V, Gennaro E, Franchi S, Cecconi M, Antonucci I, Tommasi M, Palka G, Coviello D, Stuppia L, Grasso M (2013) MS-MLPA analysis for FMR1 gene: evaluation in a routine diagnostic setting. BMC Med Genet 14:79. doi:10.1186/1471-2350-14-79

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Godler DE, Slater HR, Amor D, Loesch DZ (2010) Methylation analysis of fragile X-related epigenetic elements may provide a suitable newborn screening test for fragile X syndrome. Genet Med 12:595. doi:10.1097/GIM.0b013e3181f07088

    Article  PubMed  PubMed Central  Google Scholar 

  • Gold B, Radu D, Balanko A, Chiang CS (2000) Diagnosis of fragile X syndrome by Southern blot hybridization using a chemiluminescent probe: a laboratory protocol. Mol Diagn 5:169–178. doi:10.1054/modi.2000.9404

    Article  CAS  PubMed  Google Scholar 

  • Grasso M, Boon EM, Filipovic-Sadic S, van Bunderen PA, Gennaro E, Cao R, Latham GJ, Hadd AG, Coviello DA (2014) A novel methylation PCR that offers standardized determination of FMR1 methylation and CGG repeat length without southern blot analysis. J Mol Diagn 16:23–31. doi:10.1016/j.jmoldx.2013.09.004

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Hagerman RJ, Hagerman P (2016) Fragile X-associated tremor/ataxia syndrome—features, mechanisms and management. Nat Rev Neurol 12:403–412. doi:10.1038/nrneurol.2016.82

    Article  CAS  PubMed  Google Scholar 

  • Hagerman RJ, Hull CE, Safanda JF, Carpenter I, Staley LW, O’Connor RA, Seydel C, Mazzocco MM, Snow K, Thibodeau SN et al (1994) High functioning fragile X males: demonstration of an unmethylated fully expanded FMR-1 mutation associated with protein expression. Am J Med Genet 51:298–308. doi:10.1002/ajmg.1320510404

    Article  CAS  PubMed  Google Scholar 

  • Hammond LS, Macias MM, Tarleton JC, Shashidhar Pai G (1997) Fragile X syndrome and deletions in FMR1: new case and review of the literature. Am J Med Genet 72:430–434

    Article  CAS  PubMed  Google Scholar 

  • Handt M, Epplen A, Hoffjan S, Mese K, Epplen JT, Dekomien G (2014) Point mutation frequency in the FMR1 gene as revealed by fragile X syndrome screening. Mol Cell Probes 28:279–283. doi:10.1016/j.mcp.2014.08.003

    Article  CAS  PubMed  Google Scholar 

  • Hayward BE, Usdin K (2017) Improved assays for AGG interruptions in Fragile X premutation carriers. J Mol Diag. doi:10.1016/j.jmoldx.2017.06.008 (in press)

    Google Scholar 

  • Hayward BE, Zhou Y, Kumari D, Usdin K (2016) A set of assays for the comprehensive analysis of FMR1 alleles in the fragile X-related disorders. J Mol Diagn 18:762–774. doi:10.1016/j.jmoldx.2016.06.001

    Article  CAS  PubMed  Google Scholar 

  • Inaba Y, Schwartz CE, Bui QM, Li X, Skinner C, Field M, Wotton T, Hagerman RJ, Francis D, Amor DJ, Hopper JL, Loesch DZ, Bretherton L, Slater HR, Godler DE (2014) Early detection of fragile X syndrome: applications of a novel approach for improved quantitative methylation analysis in venous blood and newborn blood spots. Clin Chem 60:963–973. doi:10.1373/clinchem.2013.217331

    Article  CAS  PubMed  Google Scholar 

  • Iwahashi C, Tassone F, Hagerman RJ, Yasui D, Parrott G, Nguyen D, Mayeur G, Hagerman PJ (2009) A quantitative ELISA assay for the fragile X mental retardation 1 protein. J Mol Diagn 11:281–289. doi:10.2353/jmoldx.2009.080118

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Jenkins EC, Brown WT, Krawczun MS, Duncan CJ, Lele KP, Cantu ES, Schonberg S, Golbus MS, Sekhon GS, Stark S et al (1988) Recent experience in prenatal fra(X) detection. Am J Med Genet 30:329–336

    Article  CAS  PubMed  Google Scholar 

  • Kaufmann M, Schuffenhauer A, Fruh I, Klein J, Thiemeyer A, Rigo P, Gomez-Mancilla B, Heidinger-Millot V, Bouwmeester T, Schopfer U, Mueller M, Fodor BD, Cobos-Correa A (2015) High-throughput screening using iPSC-derived neuronal progenitors to identify compounds counteracting epigenetic gene silencing in fragile X syndrome. J Biomol Screen 20:1101–1111. doi:10.1177/1087057115588287

    Article  CAS  PubMed  Google Scholar 

  • Kenneson A, Zhang F, Hagedorn CH, Warren ST (2001) Reduced FMRP and increased FMR1 transcription is proportionally associated with CGG repeat number in intermediate-length and premutation carriers. Hum Mol Genet 10:1449–1454

    Article  CAS  PubMed  Google Scholar 

  • Kumari D, Usdin K (2010) The distribution of repressive histone modifications on silenced FMR1 alleles provides clues to the mechanism of gene silencing in fragile X syndrome. Hum Mol Genet 19:4634–4642. doi:10.1093/hmg/ddq394

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Kumari D, Swaroop M, Southall N, Huang W, Zheng W, Usdin K (2015) High-Throughput screening to identify compounds that increase fragile X mental retardation protein expression in neural stem cells differentiated from fragile X syndrome patient-derived induced pluripotent stem cells. Stem Cells Transl Med 4:800–808. doi:10.5966/sctm.2014-0278

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • LaFauci G, Adayev T, Kascsak R, Kascsak R, Nolin S, Mehta P, Brown WT, Dobkin C (2013) Fragile X screening by quantification of FMRP in dried blood spots by a Luminex immunoassay. J Mol Diagn 15:508–517. doi:10.1016/j.jmoldx.2013.02.006

    Article  CAS  PubMed  Google Scholar 

  • LaFauci G, Adayev T, Kascsak R, Brown WT (2016) Detection and quantification of the fragile X mental retardation protein 1 (FMRP). Genes (Basel). doi:10.3390/genes7120121

    Google Scholar 

  • Lambiris N, Peters H, Bollmann R, Leschik G, Leisti J, Salonen R, Cobet G, Oostra BA, Willemsen R (1999) Rapid FMR1-protein analysis of fetal blood: an enhancement of prenatal diagnostics. Hum Genet 105:258–260

    Article  CAS  PubMed  Google Scholar 

  • Latham GJ, Coppinger J, Hadd AG, Nolin SL (2014) The role of AGG interruptions in fragile X repeat expansions: a twenty-year perspective. Front Genet 5:244. doi:10.3389/fgene.2014.00244

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Lessard M, Chouiali A, Drouin R, Sebire G, Corbin F (2012) Quantitative measurement of FMRP in blood platelets as a new screening test for fragile X syndrome. Clin Genet 82:472–477. doi:10.1111/j.1399-0004.2011.01798.x

    Article  CAS  PubMed  Google Scholar 

  • Liang S, Bass HN, Gao H, Astbury C, Jamehdor MR, Qu Y (2008) A pseudo-full mutation identified in fragile X assay reveals a novel base change abolishing an EcoRI restriction site. J Mol Diagn 10:469–474. doi:10.2353/jmoldx.2008.080059

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Loesch D, Hagerman R (2012) Unstable mutations in the FMR1 gene and the phenotypes. Adv Exp Med Biol 769:78–114

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Loesch DZ, Sherwell S, Kinsella G, Tassone F, Taylor A, Amor D, Sung S, Evans A (2012) Fragile X-associated tremor/ataxia phenotype in a male carrier of unmethylated full mutation in the FMR1 gene. Clin Genet 82:88–92. doi:10.1111/j.1399-0004.2011.01675.x

    Article  CAS  PubMed  Google Scholar 

  • Loomis EW, Eid JS, Peluso P, Yin J, Hickey L, Rank D, McCalmon S, Hagerman RJ, Tassone F, Hagerman PJ (2013) Sequencing the unsequenceable: expanded CGG-repeat alleles of the fragile X gene. Genome Res 23:121–128. doi:10.1101/gr.141705.112

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Lozano R, Rosero CA, Hagerman RJ (2014) Fragile X spectrum disorders. Intractable Rare Dis Res 3:134–146. doi:10.5582/irdr.2014.01022

    Article  PubMed  PubMed Central  Google Scholar 

  • Meijer H, de Graaff E, Merckx DM, Jongbloed RJ, de Die-Smulders CE, Engelen JJ, Fryns JP, Curfs PM, Oostra BA (1994) A deletion of 1.6 kb proximal to the CGG repeat of the FMR1 gene causes the clinical phenotype of the fragile X syndrome. Hum Mol Genet 3:615–620

    Article  CAS  PubMed  Google Scholar 

  • Mitas M, Yu A, Dill J, Haworth IS (1995) The trinucleotide repeat sequence d(CGG)15 forms a heat-stable hairpin containing Gsyn. Ganti base pairs. Biochemistry 34:12803–12811

    Article  CAS  PubMed  Google Scholar 

  • Monaghan KG, Lyon E, Spector EB, American College of Medical G, Genomics (2013) ACMG standards and guidelines for fragile X testing: a revision to the disease-specific supplements to the Standards and Guidelines for Clinical Genetics Laboratories of the American College of Medical Genetics and Genomics. Genet Med 15:575–586. doi:10.1038/gim.2013.61

    Article  CAS  PubMed  Google Scholar 

  • Mononen T, von Koskull H, Airaksinen RL, Juvonen V (2007) A novel duplication in the FMR1 gene: implications for molecular analysis in fragile X syndrome and repeat instability. Clin Genet 72:528–531. doi:10.1111/j.1399-0004.2007.00903.x

    Article  CAS  PubMed  Google Scholar 

  • Murray A (2000) Premature ovarian failure and the FMR1 gene. Semin Reprod Med 18:59–66

    Article  CAS  PubMed  Google Scholar 

  • Nolin SL, Glicksman A, Houck GE Jr, Brown WT, Dobkin CS (1994) Mosaicism in fragile X affected males. Am J Med Genet 51:509–512. doi:10.1002/ajmg.1320510444

    Article  CAS  PubMed  Google Scholar 

  • Nolin SL, Ding XH, Houck GE, Brown WT, Dobkin C (2008) Fragile X full mutation alleles composed of few alleles: implications for CGG repeat expansion. Am J Med Genet A 146A:60–65. doi:10.1002/ajmg.a.32087

    Article  CAS  PubMed  Google Scholar 

  • Nolin SL, Sah S, Glicksman A, Sherman SL, Allen E, Berry-Kravis E, Tassone F, Yrigollen C, Cronister A, Jodah M, Ersalesi N, Dobkin C, Brown WT, Shroff R, Latham GJ, Hadd AG (2013) Fragile X AGG analysis provides new risk predictions for 45–69 repeat alleles. Am J Med Genet A 161A:771–778. doi:10.1002/ajmg.a.35833

    Article  PubMed  CAS  Google Scholar 

  • Nolin SL, Glicksman A, Ersalesi N, Dobkin C, Brown WT, Cao R, Blatt E, Sah S, Latham GJ, Hadd AG (2015) Fragile X full mutation expansions are inhibited by one or more AGG interruptions in premutation carriers. Genet Med 17:358–364. doi:10.1038/gim.2014.106

    Article  CAS  PubMed  Google Scholar 

  • Nygren AO, Lens SI, Carvalho R (2008) Methylation-specific multiplex ligation-dependent probe amplification enables a rapid and reliable distinction between male FMR1 premutation and full-mutation alleles. J Mol Diagn 10:496–501. doi:10.2353/jmoldx.2008.080053

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Oberle I, Rousseau F, Heitz D, Kretz C, Devys D, Hanauer A, Boue J, Bertheas MF, Mandel JL (1991) Instability of a 550-base pair DNA segment and abnormal methylation in fragile X syndrome. Science 252:1097–1102. doi:10.1126/science.252.5009.1097

    Article  CAS  PubMed  Google Scholar 

  • Oh SY, He F, Krans A, Frazer M, Taylor JP, Paulson HL, Todd PK (2015) RAN translation at CGG repeats induces ubiquitin proteasome system impairment in models of fragile X-associated tremor ataxia syndrome. Hum Mol Genet 24:4317–4326. doi:10.1093/hmg/ddv165

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Orpana AK, Ho TH, Stenman J (2012) Multiple heat pulses during PCR extension enabling amplification of GC-rich sequences and reducing amplification bias. Anal Chem 84:2081–2087. doi:10.1021/ac300040j

    Article  CAS  PubMed  Google Scholar 

  • Pergolizzi RG, Erster SH, Goonewardena P, Brown WT (1992) Detection of full fragile X mutation. Lancet 339:271–272

    Article  CAS  PubMed  Google Scholar 

  • Pieretti M, Zhang FP, Fu YH, Warren ST, Oostra BA, Caskey CT, Nelson DL (1991) Absence of expression of the FMR-1 gene in fragile X syndrome. Cell 66:817–822

    Article  CAS  PubMed  Google Scholar 

  • Pietrobono R, Pomponi MG, Tabolacci E, Oostra B, Chiurazzi P, Neri G (2002) Quantitative analysis of DNA demethylation and transcriptional reactivation of the FMR1 gene in fragile X cells treated with 5-azadeoxycytidine. Nucleic Acids Res 30:3278–3285

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Pretto DI, Mendoza-Morales G, Lo J, Cao R, Hadd A, Latham GJ, Durbin-Johnson B, Hagerman R, Tassone F (2014) CGG allele size somatic mosaicism and methylation in FMR1 premutation alleles. J Med Genet 51:309–318. doi:10.1136/jmedgenet-2013-102021

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Quartier A, Poquet H, Gilbert-Dussardier B, Rossi M, Casteleyn AS, Portes VD, Feger C, Nourisson E, Kuentz P, Redin C, Thevenon J, Mosca-Boidron AL, Callier P, Muller J, Lesca G, Huet F, Geoffroy V, El Chehadeh S, Jung M, Trojak B, Le Gras S, Lehalle D, Jost B, Maury S, Masurel A, Edery P, Thauvin-Robinet C, Gerard B, Mandel JL, Faivre L, Piton A (2017) Intragenic FMR1 disease-causing variants: a significant mutational mechanism leading to Fragile-X syndrome. Eur J Hum Genet 25:423–431. doi:10.1038/ejhg.2016.204

    Article  CAS  PubMed  Google Scholar 

  • Rajan-Babu IS, Law HY, Yoon CS, Lee CG, Chong SS (2015) Simplified strategy for rapid first-line screening of fragile X syndrome: closed-tube triplet-primed PCR and amplicon melt peak analysis. Expert Rev Mol Med 17:e7. doi:10.1017/erm.2015.5

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Rees WA, Yager TD, Korte J, von Hippel PH (1993) Betaine can eliminate the base pair composition dependence of DNA melting. Biochemistry 32:137–144

    Article  CAS  PubMed  Google Scholar 

  • Rife M, Nadal A, Mila M, Willemsen R (2004) Immunohistochemical FMRP studies in a full mutated female fetus. Am J Med Genet A 124A:129–132. doi:10.1002/ajmg.a.20342

    Article  CAS  PubMed  Google Scholar 

  • Rocchi M, Pecile V, Archidiacono N, Monni G, Dumez Y, Filippi G (1985) Prenatal diagnosis of the fragile-X in male monozygotic twins: discordant expression of the fragile site in amniocytes. Prenat Diagn 5:229–231

    Article  CAS  PubMed  Google Scholar 

  • Rousseau F, Heitz D, Biancalana V, Blumenfeld S, Kretz C, Boue J, Tommerup N, Van Der Hagen C, DeLozier-Blanchet C, Croquette MF et al (1991) Direct diagnosis by DNA analysis of the fragile X syndrome of mental retardation. N Engl J Med 325:1673–1681. doi:10.1056/NEJM199112123252401

    Article  CAS  PubMed  Google Scholar 

  • Saluto A, Brussino A, Tassone F, Arduino C, Cagnoli C, Pappi P, Hagerman P, Migone N, Brusco A (2005) An enhanced polymerase chain reaction assay to detect pre- and full mutation alleles of the fragile X mental retardation 1 gene. J Mol Diagn 7:605–612. doi:10.1016/S1525-1578(10)60594-6

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Schenkel LC, Schwartz C, Skinner C, Rodenhiser DI, Ainsworth PJ, Pare G, Sadikovic B (2016) Clinical Validation of Fragile X Syndrome Screening by DNA Methylation Array. J Mol Diagn 18:834–841. doi:10.1016/j.jmoldx.2016.06.005

    Article  CAS  PubMed  Google Scholar 

  • Schutzius G, Bleckmann D, Kapps-Fouthier S, di Giorgio F, Gerhartz B, Weiss A (2013) A quantitative homogeneous assay for fragile X mental retardation 1 protein. J Neurodev Disord 5:8. doi:10.1186/1866-1955-5-8

    Article  PubMed  PubMed Central  Google Scholar 

  • Sellier C, Rau F, Liu Y, Tassone F, Hukema RK, Gattoni R, Schneider A, Richard S, Willemsen R, Elliott DJ, Hagerman PJ, Charlet-Berguerand N (2010) Sam68 sequestration and partial loss of function are associated with splicing alterations in FXTAS patients. EMBO J 29:1248–1261. doi:10.1038/emboj.2010.21

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Sellier C, Freyermuth F, Tabet R, Tran T, He F, Ruffenach F, Alunni V, Moine H, Thibault C, Page A, Tassone F, Willemsen R, Disney MD, Hagerman PJ, Todd PK, Charlet-Berguerand N (2013) Sequestration of DROSHA and DGCR8 by expanded CGG RNA repeats alters microRNA processing in fragile X-associated tremor/ataxia syndrome. Cell Rep 3:869–880. doi:10.1016/j.celrep.2013.02.004

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Sherman SL (2000) Premature ovarian failure in the fragile X syndrome. Am J Med Genet 97:189–194. doi:10.1002/1096-8628(200023)97:3<189:AID-AJMG1036>3.0.CO;2-J

    Article  CAS  PubMed  Google Scholar 

  • Smeets HJ, Smits AP, Verheij CE, Theelen JP, Willemsen R, van de Burgt I, Hoogeveen AT, Oosterwijk JC, Oostra BA (1995) Normal phenotype in two brothers with a full FMR1 mutation. Hum Mol Genet 4:2103–2108

    Article  CAS  PubMed  Google Scholar 

  • Stoger R, Kajimura TM, Brown WT, Laird CD (1997) Epigenetic variation illustrated by DNA methylation patterns of the fragile-X gene FMR1. Hum Mol Genet 6:1791–1801

    Article  CAS  PubMed  Google Scholar 

  • Sutcliffe JS, Nelson DL, Zhang F, Pieretti M, Caskey CT, Saxe D, Warren ST (1992) DNA methylation represses FMR-1 transcription in fragile X syndrome. Hum Mol Genet 1:397–400

    Article  CAS  PubMed  Google Scholar 

  • Sutherland GR, Ashforth PL (1979) X-linked mental retardation with macro-orchidism and the fragile site at Xq 27 or 28. Hum Genet 48:117–120

    Article  CAS  PubMed  Google Scholar 

  • Tabolacci E, Moscato U, Zalfa F, Bagni C, Chiurazzi P, Neri G (2008a) Epigenetic analysis reveals a euchromatic configuration in the FMR1 unmethylated full mutations. Eur J Hum Genet 16:1487–1498. doi:10.1038/ejhg.2008.130

    Article  CAS  PubMed  Google Scholar 

  • Tabolacci E, Pomponi MG, Pietrobono R, Chiurazzi P, Neri G (2008b) A unique case of reversion to normal size of a maternal premutation FMR1 allele in a normal boy. Eur J Hum Genet 16:209–214. doi:10.1038/sj.ejhg.5201949

    Article  CAS  PubMed  Google Scholar 

  • Tarleton J, Kenneson A, Taylor AK, Crandall K, Fletcher R, Casey R, Hart PS, Hatton D, Fisch G, Warren ST (2002) A single base alteration in the CGG repeat region of FMR1: possible effects on gene expression and phenotype. J Med Genet 39:196–200

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Tassone F, Adams J, Berry-Kravis EM, Cohen SS, Brusco A, Leehey MA, Li L, Hagerman RJ, Hagerman PJ (2007a) CGG repeat length correlates with age of onset of motor signs of the fragile X-associated tremor/ataxia syndrome (FXTAS). Am J Med Genet B Neuropsychiatr Genet 144B:566–569. doi:10.1002/ajmg.b.30482

    Article  CAS  PubMed  Google Scholar 

  • Tassone F, Beilina A, Carosi C, Albertosi S, Bagni C, Li L, Glover K, Bentley D, Hagerman PJ (2007b) Elevated FMR1 mRNA in premutation carriers is due to increased transcription. RNA 13:555–562. doi:10.1261/rna.280807

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Tassone F, Pan R, Amiri K, Taylor AK, Hagerman PJ (2008) A rapid polymerase chain reaction-based screening method for identification of all expanded alleles of the fragile X (FMR1) gene in newborn and high-risk populations. J Mol Diagn 10:43–49. doi:10.2353/jmoldx.2008.070073

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Tassone F, Iong KP, Tong TH, Lo J, Gane LW, Berry-Kravis E, Nguyen D, Mu LY, Laffin J, Bailey DB, Hagerman RJ (2012) FMR1 CGG allele size and prevalence ascertained through newborn screening in the United States. Genome Med 4:100. doi:10.1186/gm401

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Todd PK, Oh SY, Krans A, Pandey UB, Di Prospero NA, Min KT, Taylor JP, Paulson HL (2010) Histone deacetylases suppress CGG repeat-induced neurodegeneration via transcriptional silencing in models of fragile X tremor ataxia syndrome. PLoS Genet 6:e1001240. doi:10.1371/journal.pgen.1001240

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Usdin K, Woodford KJ (1995) CGG repeats associated with DNA instability and chromosome fragility form structures that block DNA synthesis in vitro. Nucleic Acids Res 23:4202–4209

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Willemsen R, Smits A, Mohkamsing S, van Beerendonk H, de Haan A, de Vries B, van den Ouweland A, Sistermans E, Galjaard H, Oostra BA (1997) Rapid antibody test for diagnosing fragile X syndrome: a validation of the technique. Hum Genet 99:308–311

    Article  CAS  PubMed  Google Scholar 

  • Willemsen R, Anar B, De Diego Otero Y, de Vries BB, Hilhorst-Hofstee Y, Smits A, van Looveren E, Willems PJ, Galjaard H, Oostra BA (1999) Noninvasive test for fragile X syndrome, using hair root analysis. Am J Hum Genet 65:98–103

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Willemsen R, Smits A, Severijnen LA, Jansen M, Jacobs A, De Bruyn E, Oostra B (2003) Predictive testing for cognitive functioning in female carriers of the fragile X syndrome using hair root analysis. J Med Genet 40:377–379

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Wohrle D, Salat U, Glaser D, Mucke J, Meisel-Stosiek M, Schindler D, Vogel W, Steinbach P (1998) Unusual mutations in high functioning fragile X males: apparent instability of expanded unmethylated CGG repeats. J Med Genet 35:103–111

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Yrigollen CM, Durbin-Johnson B, Gane L, Nelson DL, Hagerman R, Hagerman PJ, Tassone F (2012) AGG interruptions within the maternal FMR1 gene reduce the risk of offspring with fragile X syndrome. Genet Med 14:729–736. doi:10.1038/gim.2012.34

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Yrigollen CM, Martorell L, Durbin-Johnson B, Naudo M, Genoves J, Murgia A, Polli R, Zhou L, Barbouth D, Rupchock A, Finucane B, Latham GJ, Hadd A, Berry-Kravis E, Tassone F (2014) AGG interruptions and maternal age affect FMR1 CGG repeat allele stability during transmission. J Neurodev Disord 6:24. doi:10.1186/1866-1955-6-24

    Article  PubMed  PubMed Central  Google Scholar 

  • Yu A, Barron MD, Romero RM, Christy M, Gold B, Dai J, Gray DM, Haworth IS, Mitas M (1997) At physiological pH, d(CCG)15 forms a hairpin containing protonated cytosines and a distorted helix. Biochemistry 36:3687–3699. doi:10.1021/bi9625410

    Article  CAS  PubMed  Google Scholar 

  • Zhou Y, Kumari D, Sciascia N, Usdin K (2016) CGG-repeat dynamics and FMR1 gene silencing in fragile X syndrome stem cells and stem cell-derived neurons. Mol Autism 7:42. doi:10.1186/s13229-016-0105-9

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

Grant Sponsor: Intramural program of the NIDDK, NIH (DK057808).

Author information

Authors and Affiliations

  1. Section on Gene Structure and Disease, Laboratory of Cell and Molecular Biology, National Institute of Diabetes, Digestive and Kidney Diseases, Building 8, Room 2A19, National Institutes of Health, 8 Center Drive MSC 0830, Bethesda, MD, 20892, USA

    Bruce E. Hayward, Daman Kumari & Karen Usdin

Authors
  1. Bruce E. Hayward
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Daman Kumari
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Karen Usdin
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Karen Usdin.

Ethics declarations

Conflict of interest

The authors have no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Hayward, B.E., Kumari, D. & Usdin, K. Recent advances in assays for the fragile X-related disorders. Hum Genet 136, 1313–1327 (2017). https://doi.org/10.1007/s00439-017-1840-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00439-017-1840-5

Search

Navigation